Zhenling Wang
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cancer therapeutics and mechanisms 5
-
- SARS-CoV-2 and COVID-19 Research 4
- Co-authors
- Li Yang (7 shared papers)Yuquan Wei (9 shared papers)Youfu Luo (11 shared papers)Shi H (4 shared papers)Edwin B. Fisher (1 shared paper)Chanuantong Tanasugarn (1 shared paper)Xiawei Wei (6 shared papers)Guo‐Bo Li (6 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Frontiers in Microbiology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Zhenling Wang
58 papers receiving 992 citations
Peers
Comparison fields: 5 of 113
- Microbiology 151
- Molecular Medicine 117
- Infectious Diseases 172
- Applied Microbiology and Biotechnology 18
- Endocrinology 30
Countries citing papers authored by Zhenling Wang
This map shows the geographic impact of Zhenling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenling Wang more than expected).
Fields of papers citing papers by Zhenling Wang
This network shows the impact of papers produced by Zhenling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenling Wang. The network helps show where Zhenling Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenling Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 92 | |
| 2 | 2018 | 48 | |
| 3 | 2019 | 48 | |
| 4 | 2022 | 45 | |
| 5 | 2015 | 45 | |
| 6 | 2011 | 40 | |
| 7 | 2002 | 38 | |
| 8 | 2021 | 35 | |
| 9 | 2023 | 33 | |
| 10 | 2021 | 32 | |
| 11 | 2015 | 32 | |
| 12 | 2022 | 32 | |
| 13 | 2020 | 31 | |
| 14 | 2019 | 29 | |
| 15 | 2007 | 27 | |
| 16 | 2017 | 26 | |
| 17 | 2021 | 26 | |
| 18 | 2023 | 22 | |
| 19 | 2016 | 22 | |
| 20 | 2009 | 21 |
About Zhenling Wang
Zhenling Wang is a scholar working on Molecular Biology, Infectious Diseases, Molecular Medicine, Microbiology and Immunology, having authored 61 papers that have together received 1.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Antimicrobial Peptides and Activities (5 papers), Cancer therapeutics and mechanisms (5 papers), Immune Response and Inflammation (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Bacterial Infections and Vaccines (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Microbiology (151 citations), Molecular Medicine (117 citations), Infectious Diseases (172 citations), Applied Microbiology and Biotechnology (18 citations) and Endocrinology (30 citations). Zhenling Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Li Yang, Yuquan Wei, Youfu Luo, Shi H, Edwin B. Fisher, Chanuantong Tanasugarn, Xiawei Wei, Guo‐Bo Li, Pedro Gutiérrez‐Castrellón and Xue Li. Their work appears in journals such as Signal Transduction and Targeted Therapy, Bioorganic & Medicinal Chemistry Letters, Frontiers in Microbiology, Antimicrobial Agents and Chemotherapy and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.